These results suggested that Tim-3 blockade might not only increase the infiltration of CD8+ TILs in the TME and enhance the cytotoxicity of specific antitumor CD8+ T lymphocytes but also decrease the levels of tumor-promoting cytokines. Here, HAVCR2 is linked to neoplasm.